In obese C57BL/6 male mice, short term EPO treatment (2 weeks) increases hematocrit without affecting body mass, improves glucose tolerance and insulin resistance, and shifts the inflammation of white adipose tissue associated with high fat diet feeding toward an anti-inflammatory phenotype (Alnaeeli et al., 2014). The gene discussed is EPO; the disease is Insulin resistance.